Back to results

CompletedPhase 2

Bryostatin Treatment of Moderately Severe Alzheimer's Disease

NCT04538066

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Axiom Research

Colton, California, United States

+18 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2020-08-30
Enrollment: 122 participants
Sponsor: Neurotrope Bioscience, Inc.
Purpose: treatment

Locations (19)

Axiom ResearchColton, California, United States
Pacific Research NetworkSan Diego, California, United States
JEM ResearchAtlantis, Florida, United States
Galiz ResearchHialeah, Florida, United States
ClinCloudMaitland, Florida, United States
Miami Dade Medical Research InstituteMiami, Florida, United States
Anchor NeurosciencePensacola, Florida, United States
Progressive Medical ResearchPort Orange, Florida, United States
Alzheimer's Research and Treatment CenterWellington, Florida, United States
Atlanta Center for Medical ResearchAtlanta, Georgia, United States
Columbus Memory CenterColumbus, Georgia, United States
iResearch AtlantaDecatur, Georgia, United States
iResearch SavannahSavannah, Georgia, United States
Fort Wayne Neurological CenterFort Wayne, Indiana, United States
Millenium Psychiatric AssociatesSt Louis, Missouri, United States
Neurological Associates of Albany, P. C.Albany, New York, United States
Alzheimer's Research CenterMatthews, North Carolina, United States
Summitt Research Network (Oregon)Portland, Oregon, United States
Kingfisher CooperativeSpokane, Washington, United States